Protein tyrosine phosphatase-like A (PTPLa) has been implicated in skeletal myogenesis and cardiogenesis. Mutations in PTPLa correlated with arrhythmogenic right ventricular dysplasia in humans and congenital centronuclear myopathy with severe hypotonia in dogs. The molecular mechanisms of PTPLa in myogenesis are unknown. In this report, we demonstrate that PTPLa is required for myoblast growth and differentiation. The cells lacking PTPLa remained immature and failed to differentiate into mature myotubes. The repressed MyoG expression was responsible for the impaired myoblast differentiation. Meanwhile, impeded cell growth, with an obvious S-phase arrest and compromised G 2 /M transition, was observed in PTPLa-deficient myoblasts. Further study demonstrated that the upregulation of cyclin D1 and cyclin E2 complexes, along with a compromised G 2 /M transition due to the decreased CDK1 (cyclin-dependent kinase 1) activity and upregulated p21, contributed to the mutant cell S-phase arrest and eventually led to the retarded cell growth. Finally, the transcriptional regulation of the PTPLa gene was explored. We identified PTPLa as a new target gene of the serum response factor (SRF). Skeletal-and cardiac-muscle-specific SRF knockouts resulted in significant decreases in PTPLa expression, suggesting a conserved transcriptional regulation of the PTPLa gene in mice.
Skeletal myogenesis involves multiple processes in which undifferentiated myoblasts proliferate, withdraw from the cell cycle, and differentiate into mononucleated myocytes followed by a subsequent fusion of myocytes into multinucleated myotubes. The latter are assembled into mature muscle fibers along with the expression of muscle-specific proteins. The multistep process is tightly regulated in order to secure normal myogenesis development. Extensive studies that have focused on myogenic transcriptional regulation revealed four essential myogenic regulatory factors (MRFs), MyoD (17), MyoG (myogenin) (20, 65), Myf5 (muscle regulatory factor 5) (11), and MRF4 (muscle regulatory factor 4) (10,47,55). These factors function coordinately at different stages of muscle cell fate during development and play crucial roles in myogenesis. In comparison with myogenic transcriptional regulation, there have been far fewer studies of posttranslational regulation of myogenesis. Accumulating evidence has begun to reveal that tyrosyl phosphorylation and its opposite, dephosphorylation, are important regulatory components during myogenic progression. Several representative studies have examined focal adhesion kinase (FAK), a nonreceptor tyrosine kinase also known as protein tyrosine kinase 2 (53, 54), phosphatidylinositol 3=-kinase (PI3K) (16, 30), phosphoinositide phosphatase myotubularin, and protein tyrosine phosphatase 32,33).Protein tyrosine phosphatase-like A (PTPLa) is a protein tyrosine phosphatase in which the active motif (I/V)HCXXGXXP (S/T) contains an arginine-to-proline replacement (indicated by boldface) (61). While the significance of this substitution remains ...